Dr. Pearson is an Assistant Professor of Pharmaceutical Sciences in the School of Pharmacy at the University of Maryland. His laboratory focuses on designing nanoparticles to achieve programmable immune responses for specific immunomodulation and molecular design to engineer controllable cellular interactions for targeted drug delivery. As a postdoc in Lonnie Shea's lab at the University of Michigan, he championed projects related to nanoparticle engineering and protein delivery for antigen-specific tolerance induction (i.e. autoimmunity, allergens). Notably, he worked with Cour Pharmaceuticals to develop a novel nanoparticle platform for the treatment of Celiac disease (TIMP-GLIA). This treatment is now in a Phase 2 clinical trial. As a graduate student at the University of Illinois at Chicago, Ryan worked with Seungpyo Hong to synthesize and evaluate novel polymer molecular architectures based on dendrimers and linear-block copolymers. His research has led to discoveries that improved the fundamental understanding of nanoparticle-biological (nano-bio) interactions and strategies to overcome challenges in targeted drug delivery.